Metabolically healthy obesity: Definitions, determinants and clinical implications

Reviews in Endocrine and Metabolic Disorders

Volumn 14, Issue 3, 2013, Pages 219-227

  Phillips, Catherine M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Definitions; Determinants: Diet; Inflammation, Mortality; Metabolically healthy obesity; Physical activity; Treatment

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FOOD COMPOSITION; HEALTH STATUS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEDENTARY LIFESTYLE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; MOTOR ACTIVITY; OBESITY;

EID: 84885647821     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9252-x     Document Type: Article

References (80)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431-7. 2005.
2. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
3. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-80.
4. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 2008;34:183-4.
5. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-16.
6. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168:1617-24.
7. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese, " normal-weight individual. Am J Clin Nutr. 1981;34:1617-21.
8. Aguilar-Salinas CA, Garcia EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008;93:4075-9.
9. Karelis A, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30:569-72.
10. Meigs JB, Wilson PWF, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-12.
11. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring, Md). 2010;18:911-7.
12. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes. 2010;34 Suppl 2:S18-23. 2005.
13. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011;35:971-81. 2005.
14. Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring, Md). 2011;19:624-30.
15. Gomez-Ambrosi J, Silva C, Galofre JC, et al. (2011) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (2005)
16. Dervaux N, Wubuli M, Megnien JL, Chironi G, Simon A. Comparative associations of adiposity measures with cardiometabolic risk burden in asymptomatic subjects. Atherosclerosis. 2008;201:413-7.
17. Gomez-Ambrosi J, Silva C, Galofre JC, et al. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring, Md). 2011;19:1439-44.
18. Millar S, Perry IJ, Phillips CM (2013) Surrogate measures of adiposity and cardiometabolic risk-why the uncertainty? a review of recent meta-analytic studies. J Diabetes Metab
19. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: Different prevalences using different criteria. Eur J Clin Nutr. 2010;64:1043-51.
20. Yoo HK, Choi EY, Park EW, Cheong YS, Bae RA. Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria. Korean J Fam Med. 2013;34:19-26.
21. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring, Md). 2009;17:601-5.
22. (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486-2497
23. Phillips CM, Dillon C, Harrington JM, McCarthy VJC, Kearney PM, Fitzgerald AP, Perry IJ (2013) Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS ONE
24. Kearney PM, Harrington JM, Mc Carthy VJ, Fitzgerald AP, Perry IJ (2012) Cohort profile: the Cork and Kerry diabetes and heart disease study. Int J Epidemiol
25. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA. 2013;309:71-82.
26. Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care. 2011;34:61-5.
27. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study. Diabetes Care. 2011;34:210-5.
28. Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes. 2012;2012:460321.
29. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97:2482-8.
30. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A (2013) Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care
31. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32:2297-9.
32. van der AD, Nooyens AC, van Duijnhoven FJ, Verschuren MM, Boer JM (2013) All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study. Obesity (Silver Spring, Md)
33. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: Does the definition of metabolic health matter? Diabetes Care. 2013;36:2294-300.
34. Kwon BJ, Kim DW, Her SH, et al. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metab Clin Exp. 2013;62:952-60.
35. Khan UI, Wang D, Thurston RC, et al. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: The Study of Women's Health Across the Nation (SWAN). Atherosclerosis. 2011;217:179-86.
36. Li S, Chen W, Srinivasan SR, Xu J, Berenson GS. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: The Bogalusa Heart Study. Am J Epidemiol. 2012;176 Suppl 7:S142-9.
37. Appleton SL, Seaborn CJ, Visvanathan R, et al. (2013) Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care
38. Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, et al. (2013) Metabolically healthy but obese, a matter of time? findings from the prospective Pizarra study. J Clin Endocrinol Metab
39. Neel JV. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353-62.
40. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia. 1992;35:595-601.
41. Popkin PB. Nutritional patterns and transitions. Popul Dev Rev. 1993;19:138-57.
42. Clayton P, Rowbotham J. An unsuitable and degraded diet? part one: Public health lessons from the mid-Victorian working class diet. J R Soc Med. 2008;101:282-9.
43. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7.
44. Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care. 2009;12:438-43.
45. Hankinson AL, Daviglus ML, Van Horn L, et al. (2012) Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring, Md)
46. Manu P, Ionescu-Tirgoviste C, Tsang J, Napolitano BA, Lesser ML, Correll CU. Dysmetabolic signals in "metabolically healthy" obesity. Obes Res Clin Pract. 2012;6:e9-e20.
47. Pajunen P, Kotronen A, Korpi-Hyovalti E, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: The FIN-D2D survey. BMC Publ Health. 2011;11:754.
48. Choi J, Se-Young O, Lee D, et al. Characteristics of diet patterns in metabolically obese, normal weight adults (Korean National Health and Nutrition Examination Survey III, 2005). Nutr Metab Cardiovasc Dis. 2012;22:567-74.
49. Ekelund U, Besson H, Luan J, et al. Physical activity and gain in abdominal adiposity and body weight: Prospective cohort study in 288,498 men and women. Am J Clin Nutr. 2011;93:826-35.
50. Haskell WL, Blair SN, Hill JO. Physical activity: Health outcomes and importance for public health policy. Prev Med. 2009;49:280-2.
51. Kesaniemi YK, Danforth Jr E, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA. Dose-response issues concerning physical activity and health: An evidence-based symposium. Med Sci Sports Exerc. 2001;33:S351-8.
52. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716-25.
53. Sattelmair J, Pertman J, Ding EL, Kohl 3rd HW, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: A meta-analysis. Circulation. 2011;124:789-95.
54. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
55. Chau JY, Grunseit A, Midthjell K, et al. (2013) Sedentary behaviour and risk of mortality from all-causes and cardiometabolic diseases in adults: evidence from the HUNT3 population cohort. Br J Sports Med
56. Ford ES, Caspersen CJ. Sedentary behaviour and cardiovascular disease: A review of prospective studies. Int J Epidemiol. 2012;41:1338-53.
57. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: An analysis of burden of disease and life expectancy. Lancet. 2012;380:219-29.
58. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC. Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? a cross-sectional study. BMC Publ Health. 2010;10:723.
59. Blair SN, LaMonte MJ. Commentary: Current perspectives on obesity and health: Black and white, or shades of grey? Int J Epidemiol. 2006;35:69-72. discussion 81-62.
60. Alam I, Ng TP, Larbi A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? the aging perspective. Mediat Inflamm. 2012;2012:456456.
61. Doumatey AP, Bentley AR, Zhou J, Huang H, Adeyemo A, Rotimi CN. Paradoxical hyperadiponectinemia is associated with the Metabolically Healthy Obese (MHO) phenotype in African Americans. J Endocrinol Metab. 2012;2:51-65.
62. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145-50.
63. Koster A, Stenholm S, Alley DE, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring, Md). 2010;18:2354-61.
64. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: Low inflammation and LDL oxidation in MHO women. Int J Obes. 2006;30:1529-34. 2005.
65. Wildman RP, Kaplan R, Manson JE, et al. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring, Md). 2011;19:1482-91.
66. Marques-Vidal P, Velho S, Waterworth D, Waeber G, von Kanel R, Vollenweider P. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used. Eur J Clin Nutr. 2012;66:426-35.
67. O'Connell J, Lynch L, Hogan A, Cawood TJ, O'Shea D. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J Clin Endocrinol Metab. 2011;96:E680-4.
68. Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol. 2010;176:1364-76.
69. Phillips CM, Perry IJ (2013) Does inflammation determine metabolic health status in obese and non-obese adults? J Clin Endocrinol Metab
70. Phillips CM, Tierney AC, Perez-Martinez P, et al. Obesity and body fat classification in the metabolic syndrome: Impact on cardiometabolic risk metabotype. Obesity (Silver Spring, Md). 2013;21:E154-61.
71. (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S-209S
72. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care. 2010;33:1957-9.
73. Kantartzis K, Machann J, Schick F, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54:864-8.
74. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: Effect of an energy-restricted diet. Diabetologia. 2008;51:1752-4.
75. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397-415.
76. Lau DC. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ. 2007;176:1103-6.
77. Stern JS, Hirsch J, Blair SN, et al. Weighing the options: Criteria for evaluating weight-management programs. The committee to develop criteria for evaluating the outcomes of approaches to prevent and treat obesity. Obes Res. 1995;3:591-604.
78. Arsenault BJ, Cote M, Cartier A, et al. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis. 2009;207:530-3.
79. Liu RH, Wharton S, Sharma AM, Ardern CI, Kuk JL (2013) Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults. Obesity (Silver Spring, Md)
80. Sesti G, Folli F, Perego L, Hribal ML, Pontiroli AE. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS ONE. 2011;6:e17737.